Compare · CLOV vs HUM
CLOV vs HUM
Side-by-side comparison of Clover Health Investments Corp. (CLOV) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CLOV and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $43.12B, about 16.2x CLOV ($2.67B).
- Over the past year, CLOV is up 77.8% and HUM is up 50.5% - CLOV leads by 27.3 points.
- CLOV has been more active in the news (9 items in the past 4 weeks vs 4 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 12 for CLOV).
- Company
- Clover Health Investments Corp.
- Humana Inc.
- Price
- $5.05-1.37%
- $359.22-0.42%
- Market cap
- $2.67B
- $43.12B
- 1M return
- +40.28%
- +18.33%
- 1Y return
- +77.82%
- +50.55%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 9
- 4
- Recent ratings
- 12
- 25
Clover Health Investments Corp.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest CLOV
- Clover Health Investments Corp. filed SEC Form 8-K: Other Events
- CEO, Medicare Advantage Reynoso Jamie L. sold $11,281 worth of shares (2,360 units at $4.78) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,841,211 units (SEC Form 4)
- VP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $58,816 worth of shares (12,102 units at $4.86), decreasing direct ownership by 4% to 299,067 units (SEC Form 4) (for tax liability)
- Clover Health Investments Corp. filed SEC Form 8-K: Leadership Update
- Chief Legal Officer Soares Karen sold $21,579 worth of shares (4,681 units at $4.61), decreasing direct ownership by 0.30% to 1,567,741 units (SEC Form 4) (withholding obligation)
- CEO, Medicare Advantage Reynoso Jamie L. sold $29,274 worth of shares (6,350 units at $4.61), decreasing direct ownership by 0.22% to 2,843,571 units (SEC Form 4) to satisfy withholding obligation
- Clover Health Investments Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- CEO, Medicare Advantage Reynoso Jamie L. sold $35,789 worth of shares (7,289 units at $4.91) as part of a pre-agreed trading plan, decreasing direct ownership by 0.26% to 2,849,921 units (SEC Form 4)
- Clover Health Investments Corp. filed SEC Form 8-K: Other Events
- CEO, Counterpart Health Wai Conrad sold $879,500 worth of shares (220,426 units at $3.99) as part of a pre-agreed trading plan (SEC Form 4)
Latest HUM
- Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
- Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
- Humana Announces Agreement to Divest Minority Interest in Gentiva
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)